vicarious surgical - RBOT

RBOT

Close Chg Chg %
8.74 -0.07 -0.80%

Closed Market

8.67

-0.07 (0.80%)

Volume: 22.73K

Last Updated:

Aug 1, 2025, 3:59 PM EDT

Company Overview: vicarious surgical - RBOT

RBOT Key Data

Open

$8.94

Day Range

8.50 - 9.05

52 Week Range

4.27 - 18.99

Market Cap

$52.56M

Shares Outstanding

5.93M

Public Float

2.96M

Beta

1.41

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$10.44

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

32.75K

 

RBOT Performance

1 Week
 
-21.03%
 
1 Month
 
16.43%
 
3 Months
 
7.13%
 
1 Year
 
47.91%
 
5 Years
 
-97.05%
 

RBOT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About vicarious surgical - RBOT

Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It also designs surgical robotics. The company was founded by Adam Sachs, Sammy Khalifa, and Barry Greene on May 1, 2014 and is headquartered in Waltham, MA.

RBOT At a Glance

Vicarious Surgical, Inc.
78 Fourth Avenue
Waltham, Massachusetts 02451
Phone 1-617-868-1700 Revenue 0.00
Industry Medical Specialties Net Income -63,223,000.00
Sector Health Technology Employees 123
Fiscal Year-end 12 / 2025
View SEC Filings

RBOT Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio 1.668
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -0.654
Enterprise Value to Sales N/A
Total Debt to Enterprise Value 0.327

RBOT Efficiency

Revenue/Employee N/A
Income Per Employee -514,008.13
Receivables Turnover N/A
Total Asset Turnover N/A

RBOT Liquidity

Current Ratio 6.743
Quick Ratio 6.743
Cash Ratio 6.404

RBOT Profitability

Gross Margin N/A
Operating Margin N/A
Pretax Margin N/A
Net Margin N/A
Return on Assets -67.408
Return on Equity -87.405
Return on Total Capital -104.53
Return on Invested Capital -73.937

RBOT Capital Structure

Total Debt to Total Equity 29.519
Total Debt to Total Capital 22.792
Total Debt to Total Assets 20.356
Long-Term Debt to Equity 26.911
Long-Term Debt to Total Capital 20.778
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Vicarious Surgical - RBOT

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
- - - -
-
Sales Growth
- - - -
-
Cost of Goods Sold (COGS) incl D&A
316.00K 1.94M 1.85M 2.11M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
316.00K 1.94M 1.85M 2.11M
Depreciation
316.00K 1.94M 1.85M 2.11M
Amortization of Intangibles
- - - -
-
COGS Growth
- +513.92% -4.43% +13.65%
Gross Income
(316.00K) (1.94M) (1.85M) (2.11M)
Gross Income Growth
- -513.92% +4.43% -13.65%
Gross Profit Margin
- - - -
-
2021 2022 2023 2024 5-year trend
SG&A Expense
37.91M 78.14M 78.81M 64.45M
Research & Development
22.06M 41.96M 45.72M 38.05M
Other SG&A
15.85M 36.18M 33.09M 26.40M
SGA Growth
+10,659.62% +106.13% +0.86% -18.23%
Other Operating Expense
- - - -
-
Unusual Expense
(3.09M) (84.00M) (5.19M) (43.00K)
EBIT after Unusual Expense
(35.14M) 3.92M (75.47M) (66.51M)
Non Operating Income/Expense
20.00K 1.44M 4.43M 3.29M
Non-Operating Interest Income
20.00K 1.44M 4.43M 3.29M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- 89.00K 200.00K 25.00K
Interest Expense Growth
- +124.72% -87.50% -100.00%
Gross Interest Expense
- 89.00K 200.00K 25.00K
Interest Capitalized
- - - -
-
Pretax Income
(35.21M) 5.16M (71.07M) (63.22M)
Pretax Income Growth
-21,743.55% +114.65% -1,478.15% +11.04%
Pretax Margin
- - - -
-
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(35.21M) 5.16M (71.07M) (63.22M)
Minority Interest Expense
- - - -
-
Net Income
(35.21M) 5.16M (71.07M) (63.22M)
Net Income Growth
-21,743.55% +114.65% -1,478.15% +11.04%
Net Margin Growth
- - - -
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(35.21M) 5.16M (71.07M) (63.22M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(35.21M) 5.16M (71.07M) (63.22M)
EPS (Basic)
-10.9236 1.2702 -14.6031 -10.742
EPS (Basic) Growth
-9,635.83% +111.63% -1,249.67% +26.44%
Basic Shares Outstanding
3.22M 4.06M 4.87M 5.89M
EPS (Diluted)
-10.9236 1.2132 -14.6031 -10.742
EPS (Diluted) Growth
-9,635.83% +111.11% -1,303.68% +26.44%
Diluted Shares Outstanding
3.22M 4.25M 4.87M 5.89M
EBITDA
(37.91M) (78.14M) (78.81M) (64.45M)
EBITDA Growth
-10,659.56% -106.13% -0.86% +18.23%
EBITDA Margin
- - - -
-

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 10.75
Number of Ratings 3 Current Quarters Estimate -2.403
FY Report Date 09 / 2025 Current Year's Estimate -9.43
Last Quarter’s Earnings -2.61 Median PE on CY Estimate N/A
Year Ago Earnings -10.75 Next Fiscal Year Estimate -7.003
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 3
Mean Estimate -2.40 -1.96 -9.43 -7.00
High Estimates -2.21 -1.05 -8.66 -3.73
Low Estimate -2.58 -2.60 -10.37 -10.19
Coefficient of Variance -7.72 -41.29 -9.20 -46.13

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Vicarious Surgical - RBOT

Date Name Shares Transaction Value
Jun 5, 2025 Sammy Khalifa Chief Technology Officer; Director 35,630 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.25 per share 258,317.50
Jun 5, 2025 Adam Sachs CEO; Director 50,723 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $7.22 per share 366,220.06
Aug 22, 2024 William John Kelly CFO and Treasurer 13,986 Other acquisition or disposition 0.00
Aug 22, 2024 William John Kelly CFO and Treasurer 13,893 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $6.3 per share 87,525.90

Vicarious Surgical in the News